Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920
NeutralFinancial Markets

Parkman Healthcare has sold its shares in Spruce Biosciences for a total of $4,920. This transaction reflects the ongoing adjustments in their investment portfolio, which is significant as it may indicate a shift in their strategic focus or financial strategy. Understanding these moves can provide insights into the healthcare investment landscape.
— Curated by the World Pulse Now AI Editorial System